Vernon Hoeppner

Dr. Vernon Hoeppner serves as Professor in the Division of Respirology, Critical Care and Sleep Medicine at the University of Saskatchewan, where he pioneered North America's first Directly Observed Therapy (DOT) program for tuberculosis treatment. His career spans clinical practice, provincial TB program leadership, and research focused on health equity among Indigenous populations in Saskatchewan and the Canadian prairies, emphasizing that "therapy is only as good as relationships and trust with patients and communities."

His research interests center on Tuberculosis epidemiology, Respiratory medicine, and Health disparities, with particular focus on Indigenous health outcomes, treatment adherence, and social determinants of disease. Hoeppner's work integrates clinical practice with public health strategy, examining TB transmission dynamics, cost-effectiveness of interventions, and genomic epidemiology of Mycobacterium tuberculosis strains.

Analysis of his 2014-2025 publications reveals evolving research trajectories: early work concentrated on TB transmission in Indigenous communities and treatment protocols, while recent studies expanded into genomic epidemiology (2024), health economics of latent TB treatment (2020), and climate-disease interactions in pandemic modeling (2025). His scholarship consistently addresses health inequities through both quantitative epidemiological methods and qualitative patient-centered approaches.